Mosapride citrate is a selective SR-4 agonist and SR-3 antagonist.

Mosapride Citrate
| Description | |
|---|---|
| 4-amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]morpholin-2-yl]methyl]benzamide; 2-hydroxypropane-1,2,3-tricarboxylic acid; dihydrate | |
| 112885-42-4 | |
| C21H25CIFN3O3C6H8O7 | |
| (+-)-4-amino-5-chloro-2-ethoxy-n-((4-(4-fluorobenzyl)-2-morpholinyl)methyl)b;as4370;benzamide,4-amino-5-chloro-2-ethoxy-n-((4-((4-fluorophenyl)methyl)-2-morpholin;enzamidecitrate;yl)methyl)-,2-hydroxy-1,2,3-propanetricarboxylate(1:1);4-amino-5-chloro-2-ethoxy-N-{[4-(4-fluorobenzyl)morpholin-2-yl]methyl}benzamide 2-hydroxypropane-1,2,3-tricarboxylate (1:1);4-amino-5-chloro-2-ethoxy-N-{[4-(4-fluorobenzyl)morpholin-2-yl]methyl}benzamide 2-hydroxypropane-1,2,3-tricarboxylate dihydrate (salt); | |
| A selective SR-4 activator and a SR-3 inhibitor | |